Detalhe da pesquisa
1.
Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.
BMC Cancer
; 24(1): 178, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317126
2.
Characterization and Anti-Aging Activity of Polysaccharides from Akebia trifoliata Fruit Separated by an Aqueous Two-Phase System.
Plant Foods Hum Nutr
; 78(1): 154-159, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385463
3.
Junctophilin-2 allosterically interacts with ryanodine receptor type 2 to regulate calcium release units in mouse cardiomyocytes.
Gen Physiol Biophys
; 41(2): 133-140, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416176
4.
Physicochemical Characterization of a Fern Polysaccharide from Alsophila spinulosa Leaf and Its Anti-Aging Activity in Caenorhabditis elegans.
Chem Biodivers
; 19(10): e202200156, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039474
5.
Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter.
Biochem Biophys Res Commun
; 523(1): 1-5, 2020 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822342
6.
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.
Cancer Cell Int
; 20(1): 574, 2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317527
7.
Diisopropylethylamine-triggered, highly efficient, self-catalyzed regioselective acylation of carbohydrates and diols.
Org Biomol Chem
; 16(31): 5591-5597, 2018 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027976
8.
GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Exp Cell Res
; 359(2): 405-414, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823831
9.
Correction to: Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.
Cancer Cell Int
; 21(1): 289, 2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078381
10.
[Expression and purification of DNA binding domain of NR4A1].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 40(4): 345-50, 2015 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-25931227
11.
Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib.
Front Oncol
; 14: 1405683, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835380
12.
Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A singleinstitution experience.
Oncol Lett
; 27(3): 135, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357477
13.
The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.
Front Oncol
; 14: 1331128, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454923
14.
Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.
Front Oncol
; 14: 1412472, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38887239
15.
Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data.
Front Oncol
; 14: 1353491, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357200
16.
Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment.
Front Oncol
; 14: 1331387, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706592
17.
Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients.
Medicine (Baltimore)
; 102(29): e33543, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478263
18.
Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.
Front Med (Lausanne)
; 10: 1256685, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37564044
19.
Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.
Front Med (Lausanne)
; 10: 1130012, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293311
20.
Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review.
Front Pharmacol
; 14: 1257592, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37719840